OBJECTIVES: Few studies compare gastroesophageal reflux (GER) parameters of cystic fibrosis (CF) children and symptomatic non-CF children. We aimed to compare the impedance-pH (IMP-pH) parameters for these two groups and to test the hypothesis that prolonged acid exposure in CF patients is due to delayed chemical clearance (CC). METHODS: IMP-pH tracings from 16 CF children (median 8.2 years) and 16 symptomatic non-CF children (median 8.3 years) were analyzed. Software was used to generate IMP-pH reports and parameter data were extracted. IMP-pH was used to calculate the mean CC for each patient. RESULTS: pH studies showed no difference in acid GER (AGER) frequency (p = 0.587); however, mean AGER duration, duration of longest AGER, AGER index, and DeMeester scores were all significantly higher for CF patients. IMP showed no difference in GER frequency [neither acidic (p = 0.918) nor non-acidic (p = 0.277)], but total bolus clearance was more efficient in CF patients (p = 0.049). A larger percentage of total GER reached the proximal esophagus in non-CF children (p = 0.039). Analyses of two-phase AGER episodes showed that these events were more acidic (p = 0.003) and the CC phase was significantly prolonged in the CF cohort (p = 0.001). CONCLUSIONS: Compared to symptomatic non-CF children, CF children do not have more frequent reflux. Actually, they have better bolus clearance efficiency following reflux and may even have better control over the number of GER episodes that reach the proximal esophagus. CC of AGER, however, is significantly prolonged in the CF cohort, likely due to hyperacidity of refluxed gastric contents.
OBJECTIVES: Few studies compare gastroesophageal reflux (GER) parameters of cystic fibrosis (CF) children and symptomatic non-CF children. We aimed to compare the impedance-pH (IMP-pH) parameters for these two groups and to test the hypothesis that prolonged acid exposure in CF patients is due to delayed chemical clearance (CC). METHODS: IMP-pH tracings from 16 CF children (median 8.2 years) and 16 symptomatic non-CF children (median 8.3 years) were analyzed. Software was used to generate IMP-pH reports and parameter data were extracted. IMP-pH was used to calculate the mean CC for each patient. RESULTS: pH studies showed no difference in acid GER (AGER) frequency (p = 0.587); however, mean AGER duration, duration of longest AGER, AGER index, and DeMeester scores were all significantly higher for CF patients. IMP showed no difference in GER frequency [neither acidic (p = 0.918) nor non-acidic (p = 0.277)], but total bolus clearance was more efficient in CF patients (p = 0.049). A larger percentage of total GER reached the proximal esophagus in non-CF children (p = 0.039). Analyses of two-phase AGER episodes showed that these events were more acidic (p = 0.003) and the CC phase was significantly prolonged in the CF cohort (p = 0.001). CONCLUSIONS: Compared to symptomatic non-CF children, CF children do not have more frequent reflux. Actually, they have better bolus clearance efficiency following reflux and may even have better control over the number of GER episodes that reach the proximal esophagus. CC of AGER, however, is significantly prolonged in the CF cohort, likely due to hyperacidity of refluxed gastric contents.
Authors: C D Rudolph; L J Mazur; G S Liptak; R D Baker; J T Boyle; R B Colletti; W T Gerson; S L Werlin Journal: J Pediatr Gastroenterol Nutr Date: 2001 Impact factor: 2.839
Authors: Carla M Pedrosa Ribeiro; Anthony M Paradiso; Mark A Carew; Stephen B Shears; Richard C Boucher Journal: J Biol Chem Date: 2005-01-12 Impact factor: 5.157
Authors: Alicia K Olivier; Katherine N Gibson-Corley; David K Meyerholz Journal: Am J Physiol Gastrointest Liver Physiol Date: 2015-01-15 Impact factor: 4.052
Authors: Puya Gharahkhani; Rebecca C Fitzgerald; Thomas L Vaughan; Claire Palles; Ines Gockel; Ian Tomlinson; Matthew F Buas; Andrea May; Christian Gerges; Mario Anders; Jessica Becker; Nicole Kreuser; Tania Noder; Marino Venerito; Lothar Veits; Thomas Schmidt; Hendrik Manner; Claudia Schmidt; Timo Hess; Anne C Böhmer; Jakob R Izbicki; Arnulf H Hölscher; Hauke Lang; Dietmar Lorenz; Brigitte Schumacher; Andreas Hackelsberger; Rupert Mayershofer; Oliver Pech; Yogesh Vashist; Katja Ott; Michael Vieth; Josef Weismüller; Markus M Nöthen; Stephen Attwood; Hugh Barr; Laura Chegwidden; John de Caestecker; Rebecca Harrison; Sharon B Love; David MacDonald; Paul Moayyedi; Hans Prenen; R G Peter Watson; Prasad G Iyer; Lesley A Anderson; Leslie Bernstein; Wong-Ho Chow; Laura J Hardie; Jesper Lagergren; Geoffrey Liu; Harvey A Risch; Anna H Wu; Weimin Ye; Nigel C Bird; Nicholas J Shaheen; Marilie D Gammon; Douglas A Corley; Carlos Caldas; Susanne Moebus; Michael Knapp; Wilbert H M Peters; Horst Neuhaus; Thomas Rösch; Christian Ell; Stuart MacGregor; Paul Pharoah; David C Whiteman; Janusz Jankowski; Johannes Schumacher Journal: Lancet Oncol Date: 2016-08-12 Impact factor: 41.316
Authors: Frederick W Woodley; Don Hayes; Benjamin T Kopp; Melissa Moore-Clingenpeel; Rodrigo Strehl Machado; Christopher J Nemastil; Sudarshan Jadcherla; Carlo Di Lorenzo; Ajay Kaul; Hayat Mousa Journal: Transl Gastroenterol Hepatol Date: 2019-09-16
Authors: Frederick W Woodley; Melissa Moore-Clingenpeel; Rodrigo Strehl Machado; Christopher J Nemastil; Sudarshan R Jadcherla; Don Hayes; Benjamin T Kopp; Ajay Kaul; Carlo Di Lorenzo; Hayat Mousa Journal: Pediatr Gastroenterol Hepatol Nutr Date: 2017-09-26